The Antisense Therapy Market is supported by improvements in genetic sequencing and molecular diagnostics. These technologies can help researchers understand disease-associated mutations and identify RNA targets suitable for antisense-based treatment development. The Antisense Therapy Market was valued at US$ 6.17 Billion in 2025 and is expected to reach US$ 24.5 Billion by 2034, registering a...